1. Home
  2. ESQ vs EVO Comparison

ESQ vs EVO Comparison

Compare ESQ & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

N/A

Current Price

$111.95

Market Cap

941.0M

Sector

Finance

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$2.86

Market Cap

934.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ESQ
EVO
Founded
2006
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
941.0M
934.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ESQ
EVO
Price
$111.95
$2.86
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$120.33
$7.00
AVG Volume (30 Days)
81.3K
86.6K
Earning Date
04-23-2026
04-08-2026
Dividend Yield
0.76%
N/A
EPS Growth
14.20
N/A
EPS
1.40
N/A
Revenue
N/A
N/A
Revenue This Year
$35.15
$1.37
Revenue Next Year
$39.09
$10.05
P/E Ratio
$80.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$87.54
$2.31
52 Week High
$119.86
$4.80

Technical Indicators

Market Signals
Indicator
ESQ
EVO
Relative Strength Index (RSI) 58.25 47.70
Support Level $104.58 $2.63
Resistance Level $115.69 $3.78
Average True Range (ATR) 2.35 0.09
MACD 0.68 -0.03
Stochastic Oscillator 87.64 37.13

Price Performance

Historical Comparison
ESQ
EVO

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: